Clinical trial
A Phase 2 Extension of Study GCS-100-CS-4003
NCT02333955 is registered in ClinicalTrials.gov with La Jolla Pharmaceutical Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Extension of Study GCS-100-CS-4003
- Lead sponsor
- La Jolla Pharmaceutical Company
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 31, 2015
- Completion date
- July 31, 2016
- Enrollment
- 0 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease